~~<i id='FD34C6030F'><strike id='FD34C6030F'><tt id='FD34C6030F'><pre id='FD34C6030F'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：comprehensive 2025-09-28 22:43:15 Page View：3

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Lawmakers grill UnitedHealth CEO on Change cyberattack
Next article： Malaria cases in Florida and Texas: Here’s what you need to know

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

3:41SulemanDawoodandShahzadaDawoodDawoodFamilyThefamilyoftwovictimsfromthesubmersiblethatimplodednea

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

1:45RandallMargraves,right,talkstoattorneyMickGrewal,ashepreparestostandinfrontofJudgeJaniceCunningh